Pseudophakic Eyes With Presbyopia-correcting IOLs: OCT Biometry and Pyramid Aberrometry
Key facts
- Who runs it
- Prim. Prof. Dr. Oliver Findl, MBA
- Where
- Austria1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Recruiting
- People taking part
- 80 people, planned
- Started
- 4 Apr 2024
- Planned end
- 1 Jul 2026
- Type of study
- Observational, 9 groups
- Treatments tested
- Osiris-T Pyramid Wavefront Sensor - (CSO, Italy)
- Record updated
- 27 February 2026
Who can take part
- Age
- 21 years to 110 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 11 criteriaShow less
Who can take part
- Men and women aged above 21 years with prior uncomplicated cataract/IOL exchange surgery
- Willing to sign informed consent before measurements
- Corrected distance visual acuity (CDVA) of 0.1 logMAR or better
- Absence of corneal scars/dry eye disease that could falsify the light transmission of the study eye
- Total absence of posterior capsule opacification or patients who already have undergone Nd:YAG capsulotomy
- Absence of ocular comorbidity (Macular degeneration, glaucoma, amblyopia)
Who cannot take part
- Prior corneal refractive or ocular surgery
- Zonular weakness 7) Pseudoexfoliation syndrome 8) Eccentric fixation or insufficient ability to fixate (tremor, nystagmus) 9) Pregnancy
- Posterior capsule opacification
- Keratometry between <42.5 and >45 D,
- Corneal spherical aberration > 0.4 microns 5) Angle kappa > 0.4 mm
The main criteria, as questions
These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Are you between 21 and 110 years old?
This trial is currently available in Austria.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
To correlate ocular morphology from anterior segment OCT and pyramid wavefront sensing in order to comprehensively analyze pseudophakic in vivo image quality of presbyopia-correcting IOLs in cataract patients.
The 9 groups in the trial
- Acrysoft SN60WF (Alcon) - Control
Aspheric monofocal
Treatment: Osiris-T Pyramid Wavefront Sensor - (CSO, Italy)
- Acrysoft IQ Vivity (Alcon)
Refractive EDOF
Treatment: Osiris-T Pyramid Wavefront Sensor - (CSO, Italy)
- AT Lisa Tri (Carl Zeiss Meditec AG)
Diffractive multifocal
Treatment: Osiris-T Pyramid Wavefront Sensor - (CSO, Italy)
- Tecnis Symphony ZXR00 (Johnson & Johnson)
Diffractive aspheric extended depth of focus
Treatment: Osiris-T Pyramid Wavefront Sensor - (CSO, Italy)
- Tecnis Eyhance ICB00 (Johnson & Johnson)
Enhanced monofocal
Treatment: Osiris-T Pyramid Wavefront Sensor - (CSO, Italy)
- RayOne EMV (Rayner Surgical)
Enhanced monofocal
Treatment: Osiris-T Pyramid Wavefront Sensor - (CSO, Italy)
- Acunex Varo AN6V (Teleon Surgical)
Rotationally asymmetric multifocal extended depth of focus
Treatment: Osiris-T Pyramid Wavefront Sensor - (CSO, Italy)
- PureSee (Johnson & Johnson)
Refractive EDOF
Treatment: Osiris-T Pyramid Wavefront Sensor - (CSO, Italy)
- RayOne Trifocal (Rayner)
Diffractive Multifocal
Treatment: Osiris-T Pyramid Wavefront Sensor - (CSO, Italy)
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Pseudophakic Eyes Implanted With Different Presbyopia-correcting IOL Designs: 3-D Anterior Segment OCT Biometry and Pyramid Wavefront Sensing- Based Retinal Image Quality
- Criteria questions
- Built from NCT07436247, who can take part
- Record updated
- 27 February 2026